205 results on '"Minari, R"'
Search Results
2. PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
3. Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients
4. Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors:A Multicenter Cohort Study
5. Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
6. Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents
7. 5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC
8. PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
9. Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
10. NGS Testing on Plasma-based ctDNA Samples at Key Clinical Timepoints in Advanced NSCLC: Handling of Blood Samples and Real-World Experience
11. Circulating Tumor DNA Monitoring in Advanced Mutated Melanoma Treated With Immune Checkpoint Inhibitors: A Pilot Study
12. Liquid Biopsy Monitoring in BRAF-V600E Mutated NSCLC Patients Treated With Dabrafenib Plus Trametinib: A Prospective, Explorative, Multicentric Study. LiBRA_study (GOIRC-03-2020)
13. 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
14. 1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC
15. EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)
16. P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
17. 1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients
18. 165P Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
19. 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
20. P57.08 High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC
21. 1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
22. 145P High-risk breast cancer patients with RAD51-low tumors are characterized by good prognosis
23. 2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients
24. next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome -positive acute lymphoblastic leukemia
25. 7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients
26. Disorders of Sexual Differentiation: New Epigenetic Insights of Hypospadia.
27. 189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC
28. P76.52 Liquid Biopsy and PET Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC
29. Multilobular morphology: the key for biphase multifunctional nanogels
30. Evidence for Epigenetic Abnormalities of the Androgen Receptor Gene in Foreskin from Children with Hypospadias
31. 1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients
32. L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib† †Electronic supplementary information (ESI) available: pKa shift for Cys797; geometries of TSs identified with QM/MM calculations; analysis of the minimum free-energy path for Cys797 alkylation; analysis of MD replicas; convergence for US simulations; replica of simulation of Cys797 alkylation; conformational FESs obtained from each MD replica. See DOI: 10.1039/c7sc04761d
33. BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients
34. A multicenter trial focusing on the implementation of EGFR predictive mutation analysis in clinical practice on cell free circulating tumor DNA
35. Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC
36. Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
37. The Role of SHOX Gene in Idiopathic Short Stature: an Italian Multicenter Study
38. 10P - Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC
39. 1982PD - Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
40. The Role of SHOX Gene in Idiopathic Short Stature: an Italian Multicenter Study
41. Incidence of SHOX deficiency in a cohort of Italian children with idiopathic short stature
42. PARTICLE NUCLEATION USING DIFFERENT INITIATORS IN THE MINIEMULSION POLYMERIZATION OF STYRENE
43. NUTRITIONAL AND RESPIRATORY EFFECTS OF AZITHROMYCIN LONG-TERM TREATMENT IN CYSTIC FIBROSIS PATIENTS
44. Emulsion polymerization of styrene with Iso‐octyl‐3‐mercaptopropionate as chain transfer agent
45. Glucose tolerance changes in cystic fibrosis (CF) patients during a 10 years period
46. Walking distance as an outcome of antibiotic course in patients with cystic fibrosis
47. Coinvolgimento Ureterale Bilaterale Nella Sindrome di Churg-Strauss: Descrizione di un Nuovo Caso
48. Risk-Factors of Recurrence after Retropubic and Perineal Radical Prostatectomy
49. Laser treatment of bladder cancer
50. Treatment of abacterial pseudomembranous trigonitis with Nd:YAG laser. Personal experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.